Figure 4.

Example of a therapeutic approach based on the targeting of tumor extracellular vesicles (EVs). Inhibition of the EV uptake by SKOV-3 cells treated with increased concentrations of LXY30 peptide (A) by measuring fluorescence intensity in target cells *p < 0.005. (B–F) Representative laser scanning microscope images of SKOV-3 cells treated with unlabeled (B) or labeled DiL-EV in combination with different concentrations (C–F) of LXY30 peptide. Contribution from Carney et al. (168). Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.